Cardiopulmonary bypass and VA-ECMO induced immune dysfunction: common features and differences, a narrative review
Open Access
- 10 September 2024
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-15
Abstract
Cardiopulmonary bypass (CPB) and veno-arterial extracorporeal membrane oxygenation are critical tools in contemporary cardiac surgery and intensive care, respectively. While these techniques share similar components, their application contexts differ, leading to distinct immune dysfunctions which could explain the higher incidence of nosocomial infections among ECMO patients compared to those undergoing CPB. This review explores the immune modifications induced by these techniques, comparing their similarities and differences, and discussing potential treatments to restore immune function and prevent infections. The immune response to CPB and ECMO involves both humoral and cellular components. The kinin system, complement system, and coagulation cascade are rapidly activated upon blood contact with the circuit surfaces, leading to the release of pro-inflammatory mediators. Ischemia–reperfusion injury and the release of damage-associated molecular patterns further exacerbate the inflammatory response. Cellular responses involve platelets, neutrophils, monocytes, dendritic cells, B and T lymphocytes, and myeloid-derived suppressor cells, all of which undergo phenotypic and functional alterations, contributing to immunoparesis. Strategies to mitigate immune dysfunctions include reducing the inflammatory response during CPB/ECMO and enhancing immune functions. Approaches such as off-pump surgery, corticosteroids, complement inhibitors, leukocyte-depleting filters, and mechanical ventilation during CPB have shown varying degrees of success in clinical trials. Immunonutrition, particularly arginine supplementation, has also been explored with mixed results. These strategies aim to balance the inflammatory response and support immune function, potentially reducing infection rates and improving outcomes. In conclusion, both CPB and ECMO trigger significant immune alterations that increase susceptibility to nosocomial infections. Addressing these immune dysfunctions through targeted interventions is essential to improving patient outcomes in cardiac surgery and critical care settings. Future research should focus on refining these strategies and developing new approaches to better manage the immune response in patients undergoing CPB and ECMO. Although often considered similar, CPB and ECMO have distinct immune repercussions. Numerous immunomodulatory strategies have been tested in cardiac surgery patients undergoing CPB to mitigate the induced immunoparesis, but no clinical trials have been conducted for patients on ECMO. C5aR (complement component 5a receptor), CPB (cardiopulmonary bypass), DC (dendritic cells), ECMO (extracorporeal membrane oxygenation), HLA-DR (human leukocyte antigen-DR isotype), NETs (neutrophil extracellular traps), PD-1 (program cell death protein 1), ROS (reactive oxygen species), TLR (toll-like receptor). Created with BioRender.comKeywords
This publication has 133 references indexed in Scilit:
- Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devicesJournal of Cardiothoracic and Vascular Anesthesia, 1994
- Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activationPerfusion, 1994
- NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na(+)-H+ exchangeAmerican Journal of Physiology-Heart and Circulatory Physiology, 1993
- Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators.1992
- Effect of cardiopulmonary bypass on circulating lymphocyte functionThe Annals of Thoracic Surgery, 1992
- Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles.1991
- Effect of Extracorporeal Membrane Oxygenation on Leukocyte Function in NeonatesArtificial Organs, 1991
- THE ROLE OF THE COMPLEMENT-SYSTEM IN SHOCK AND TISSUE-INJURY INDUCED BY TUMOR-NECROSIS-FACTOR AND ENDOTOXIN1990
- The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.1986
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981